PRODUCTION OF TAXANE TYPE DITERPENE

    公开(公告)号:JPH07308197A

    公开(公告)日:1995-11-28

    申请号:JP10421294

    申请日:1994-05-18

    Abstract: PURPOSE:To industrially and advantageously obtain the subject compound useful as a therapeutic agent for ovarian carcinoma, mastocarcinoma, lung cancer, etc., by culturing a cell or a tissue of a plant capable of producing a taxane type terpene in the presence of a specific jasmonic acid and recovering a formed product from the culture mixture. CONSTITUTION:A cell or a tissue of a plant (e.g. Taxus baccata) capable of producing taxane type terpene is cultured in the presence of a jasmonic acid of formula I {R is a 1-4C alkyl, a group of formula II [R is OH, an OM (M is an alkali metal, an alkaline earth metal or NH4), an NHR (R is a 1-4C acyl, a 1-4C alkyl or amino acid) or an OR (R is a 1-4C alkyl or a hydrocarbon residue; (n) is an integer of 1-7]; R to R are each H or R and R , R and R or R and R may form a double bond together; the five-membered ring may be further substituted with a hydroxyl group and may form a double bond between adjoining carbon atoms} and a formed product is recovered to give the abjective taxane type terpene (e.g. taxol).

    PHOMACTIN DERIVATIVE
    69.
    发明专利

    公开(公告)号:JPH0710856A

    公开(公告)日:1995-01-13

    申请号:JP8173794

    申请日:1994-04-20

    Applicant: SANKYO CO

    Abstract: PURPOSE:To obtain a new specific phomactin derivative, which is useful as an antithrombotic agent and for prophylaxis and therapy of asthma, digestive ulcer, nephritic disorders and hypertension because of its platelet activation factor(PAF)-antagonistic action. CONSTITUTION:A strain separated from the shell of a crab (Chinecetes opilio), Phomas sp. SANK 15692 strain (FERM-BP-4175) is inoculated into a culture medium and cultured at 23 deg. in a rotatory shaking inclubator for 7 days. Then, the cultured medium is cultured in a jar fermenter at 23 deg. for 3 days, and further in a tank at 23 deg. for 12 days. The cultured liquid is mixed with ethyl acetate and filtered and the resultant crystals are recrystallized to give phomactin C of the formula I. The product is reduced with lithium aluminum hydride or the like, when needed, and the hydroxy group formed is esterified to give the objective phomactin derivative of the formula II [X is CHO, CH2OH, CH2 OOOR (R is an alkyl, aryl); A, B are each H or together form a single bond; Y is CO, CHOH].

Patent Agency Ranking